Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 17 January, 2020

JP Morgan Sec LLC

AbbVie Inc. 38.5b AMENDMENT

RNS Number : 1835A
J.P. Morgan Securities LLC
17 January 2020
 

Ap27

 

 

AMENDMENT

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.          KEY INFORMATION

 

Name of exempt principal trader

J.P Morgan Securities LLC

Company dealt in

AbbVie Inc.

Class of relevant security to which the dealings being disclosed relate (Note 1)

Common stock

Date of dealing

15 January 2020

 

2.          INTERESTS AND SHORT POSITIONS

 

(a)         Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

 

 

Long

Short

 

Number

 

(%)

Number

 

(%)

  24,066,343                 1.63

 4,477,884                  0.30

(2) Derivatives (other than options)

  3,732,203                   0.25

 1,631,641                  0.11

(3) Options and agreements to purchase/sell

  947,300                      0.06

 621,500                  0.04

Total

  28,745,846                 1.94

 6,731,025                  0.45

             

 

 

(b)         Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

 

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

             

 

Ap28

 

 

3.       DEALINGS (Note 3)

 

(a)      Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit (Note 4)

Purchase (New Borrow)

 

Purchases

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

7,696,300

 

215

2

4

4

2

2

3

48

44

21

2

2

2

29

4

2

5

7

6

14

6

4

9

7

6

10

10

2

31

3

8

3

3

10,552

57

125,577

2

3

3

3

1,400

2

2

2

5

6

 

215

100

100

100

100

100

100

100

200

100

100

100

100

200

100

100

100

100

200

100

100

200

100

100

100

100

100

400

100

200

100

100

100

200

10,552

100

100

100

100

2,500

100

57

10,010

100

100

100

100

100

100

400

5

200

1,400

753

600

100

100

200

200

200

100

2

200

100

3

100

13

12

3

100

3

200

3

100

36

58

400

NA

 

88.2000 USD

88.7600 USD

88.7700 USD

88.7900 USD

88.8000 USD

88.8100 USD

88.8500 USD

88.8875 USD

88.9280 USD

88.9481 USD

88.9500 USD

88.9800 USD

89.0000 USD

89.0166 USD

89.0200 USD

89.0300 USD

89.0400 USD

89.0500 USD

89.0800 USD

89.0886 USD

89.0900 USD

89.1100 USD

89.1200 USD

89.1214 USD

89.1300 USD

89.1400 USD

89.1420 USD

89.1500 USD

89.1787 USD

89.1800 USD

89.1875 USD

89.1900 USD

89.2100 USD

89.2246 USD

89.2575 USD

89.2600 USD

89.3100 USD

89.3200 USD

89.3300 USD

89.3400 USD

89.3793 USD

89.3800 USD

89.4100 USD

89.4500 USD

89.5800 USD

89.5900 USD

 

88.2000 USD

88.6717 USD

88.7003 USD

88.7094 USD

88.7651 USD

88.7907 USD

88.7980 USD

88.7998 USD

88.8252 USD

88.8275 USD

88.8413 USD

88.8606 USD

88.9046 USD

88.9626 USD

88.9646 USD

88.9700 USD

88.9719 USD

88.9777 USD

88.9900 USD

89.0307 USD

89.0486 USD

89.0621 USD

89.0726 USD

89.0734 USD

89.1045 USD

89.1204 USD

89.1233 USD

89.1332 USD

89.1336 USD

89.1431 USD

89.1771 USD

89.1800 USD

89.1821 USD

89.1850 USD

89.2246 USD

89.2300 USD

89.2390 USD

89.2426 USD

89.2476 USD

89.2516 USD

89.2544 USD

89.2575 USD

89.2600 USD

89.2803 USD

89.3137 USD

89.3200 USD

89.3262 USD

89.3303 USD

89.3360 USD

89.3375 USD

89.3600 USD

89.3730 USD

89.3793 USD

89.3800 USD

89.3808 USD

89.3850 USD

89.3918 USD

89.4638 USD

89.4673 USD

89.5430 USD

89.5440 USD

89.5500 USD

89.5641 USD

89.5678 USD

89.5700 USD

89.5777 USD

89.5800 USD

89.5875 USD

89.5900 USD

89.5975 USD

89.6200 USD

89.6367 USD

89.6600 USD

89.7424 USD

89.7981 USD

89.8064 USD

89.8264 USD

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 5)

Number of relevant securities

(Note 6)

Price per unit

(USD) (Note 4)

Equity Swaps

Long

 

 

 

 

Short

10,552

57

1,400

5

 

105,700

3

89.2246

89.2575

89.3793

89.5800

 

89.2600

89.5900

 

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

Ap29

 

4.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached? (Note 8)                    YES

 

 

Date of disclosure

17 January 2020

Contact name

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

Allergan plc

Nature of connection (Note 9)

Financial Advisor to Allergan plc

 

 

 

 

 

Ap31

 

 

SUPPLEMENTAL FORM 38.5(b)

 

 

 

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 38.5(b)) OPEN POSITIONS (Note 1)

 

Product name,

e.g. call option

Written or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

87,500

87,500

182,700

9,100

1,000

8,400

7,100

102,500

29,100

31,300

32,300

11,400

8,900

1,900

4,400

20,000

100,000

7,700

10,000

9,100

45,000

8,400

7,100

102,500

29,100

31,300

32,300

16,400

10,400

25,000

7,000

4,400

140,000

20,000

6,100

8,500

18,200

8,400

11,200

7,200

21,100

2,500

4,500

5,600

2,500

20,000

6,100

10,000

21,200

8,400

11,200

7,200

21,100

2,500

7,900

5,600

2,500

10,000

8,500

100,000

60.00

55.00

60.00

65.00

70.00

57.50

62.50

60.00

55.00

65.00

70.00

75.00

77.50

72.50

67.50

60.00

70.00

60.00

110.00

65.00

80.00

57.50

62.50

60.00

55.00

65.00

70.00

75.00

77.50

80.00

72.50

67.50

82.50

105.00

110.00

105.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

82.50

110.00

105.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

110.00

105.00

70.00

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

21FEB20

21FEB20

17JAN20

17JAN20

17JAN20

17JAN20

17JAN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

17JAN20

17JAN20

17JAN20

17JAN20

17JAN20

17JAN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

17JAN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

 

 

 

 

Notes

 

1.       Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.       For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rules 8 and

38.5 of the Rules. If in doubt, consult the Panel.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEFLFILLSIDLII

a d v e r t i s e m e n t